期刊文献+

氨氯地平与阿托伐他汀钙片联用治疗高血压合并冠心病研究 被引量:2

Contrastive Study of Amlodipine Alone or Combined with Atorvastatin Calcium Tablets in the Treatment of Hypertension Complicated with Coronary Heart Disease
下载PDF
导出
摘要 目的对比氨氯地平单用与联用阿托伐他汀钙片治疗高血压合并冠心病的临床效果。方法抽取2014年4月~2016年4月来我院就诊的86例高血压合并冠心病患者,随机分为对照组(n=43)和观察组(n=43)。对照组应用氨氯地平治疗,观察组给予氨氯地平联合阿托伐他汀钙片进行治疗,两组疗程均为2个月,对比两组临床疗效及治疗前后血压及血脂水平变化情况。结果治疗后,两组总有效率比较,观察组(95.3%)显著高于对照组(81.4%),具有统计学差异(P<0.05);治疗后,两组血压、血脂水平均较治疗前明显降低,且观察组降低幅度优于对照组,差异均具有统计学意义(P<0.05)。结论对于高血压合并冠心病患者,通过给予氨氯地平联合阿托伐他汀钙片进行治疗,可明显改善其血压、血脂状况,疗效优于单用氨氯地平治疗。 Objective To compare the clinical effect of amlodipine alone or combined with atorvastatin calcium tablets in the treatment of hypertension complicated with coronary heart disease.Methods A total of 86 hypertension patients with coronary heart disease admitted to our hospital from April 2014 to April 2016 were randomly divided into control group(n=43)and observation group(n=43).Patients in the control group were treated with amlodipine,while patients in the observation group were administrated with amlodipine+atorvastatin calcium tablets.Both groups were treated for a course of 2 months.The clinical efficacy and the changes of blood pressure as well as blood lipid level in the two groups were compared before and after treatment.Results After treatment,the total effective rate of the observation group as 95.3%was significantly higher than the 81.4%of the control group,the difference was statistically significant(P<0.05);After treatment,the blood pressure and the blood lipid levels of both groups decreased significantly,and the observation group decreased much more than the control group,the difference between the two groups was statistically significant(P<0.05).Conclusion Amlodipine combined with atorvastatin calcium tablets in hypertension patients with coronary heart disease can significantly improve the blood pressure and blood lipid status,and the efficacy is better than that of amlodipine alone.
作者 乔印涛 QIAO Yin-tao(SectionⅢ,Department of Cardiology,Fangcheng County People’s Hospital,Nanyang,Henan,473200,China)
出处 《临床研究》 2018年第2期31-32,共2页 Clinical Research
关键词 高血压合并冠心病 氨氯地平 阿托伐他汀钙片 hypertension combined with coronary heart disease amlodipine Atorvastatin calcium tablets
  • 相关文献

参考文献5

二级参考文献49

  • 1陈新石.高血压患者控制高血压同时降低胆固醇(联合使用络活喜和立普妥)可降低冠心病死亡和心肌梗死发作的风险[J].中华医学杂志,2007,87(10):717-717. 被引量:23
  • 2《中国高血压防治指南》修订委员会.中国高血压防治指南2010修订版[M].北京:人们卫生出版社,2010:40.
  • 3中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.68-74.
  • 4Solanki TB,Shah PA,Patel KG.Central Composite Design for Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil,Amlodipine Besylate and Hydrochlorothiazide in Tablets[J].Indian J Pharm Sci,2014(3):179-187.
  • 5Pugazhenthan T,Singh H,Kumar P,Hariharan B.Is Dysguesia Going to be a Rare or a Common Side-effect of Amlodipine[J].Ann Med Health Sci Res,2014(Suppl 1):43-44.
  • 6Pusapati RT,Kumar MK,Rapeti SS,Murthy T.Development of co-processed excipients in the design and evaluation ofatorvastatin calcium?tablets?by direct compression method[J].Int J Pharm Investig,2014(2):102-106.
  • 7Pavia A,Zamorano J,Sutradhar S,et al. Changes in calculated coronary heart disease risk using proactive multifactorial intervention versus continued usual care in Latin-American and non-Latin-American patients enrolled in the CRUCIAL trial[J]. Curr Med Res Opin,2012, 28(10):1667-76.
  • 8Li M,Xu A,Lam KS,et al. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin[J]. Postgrad Med,2011,123(6):66-71.
  • 9Neutel JM,Eaddy M,Lunacsek OE,et al. Predicted coronary heart disease risk reduction and dual blood pressure/cholesterol goal attainment in patients with hypertension treated in real-world clinical practice[J]. Clin Hvoertens (Greenwich),2010,12(6):396-406.
  • 10Zamorano J,Erdine S,Pavia A,et al. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial[J]. Curr Med Res Opin,2011,27(4):821-33.

共引文献193

同被引文献14

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部